Skip to main content
. 2020 Jul 13;2020(56):114–132. doi: 10.1093/jncimonographs/lgaa001

Table 2.

Dosimetry and other characteristics of selected radiation epidemiology studies post–BEIR VII

ID Study group or name Exposure period Exposed subjects Average (range) dose: target Dose metric Study reference Dosimetry reference(s)
Environmental
1 Chernobyl residents 1986–2000 1 256 6 (0–265) mGy, RBM* Absorbed dose (28) NA
2 TMI residents 1979 21 494 0.10 (0–0.80) mSv H  p(10) (29) (30, 31)
3 Chinese background 1905–1998 31 604 66 (0–125+) mGy, colon Absorbed dose (32) (33–35)
4 GB background 1991–1996 64 240 4 (0–31) mSv, RBM* Equivalent dose (36) (37–40)
5 Swiss background 1974–2008 2 093 660 9 (0–49) mSv Equivalent dose (41) (42, 43)
6 Techa River residents 1951–2007 17 435 60 (0–960) mGy, stomach§ Absorbed dose (44) (45–47)
7 Finnish background 1990–2011 4 372 2 (0–12) mSv, RBM*, Equivalent dose (48)
8 Taiwanese residents 1982–1995 6 242 48 (0–2363) mSv Equivalent dose (49) (50, 51)
Medical
9 Cardiac imaging patients 1996–2006 82 861 5.3 mSv per patient-year Equivalent dose (52) (53, 54)
10 French pediatric CT 2000–2010 67 274 23 (0–100+) mGy: brain; 9 (0–100+), RBM Absorbed dose (55) (56)
11 UK pediatric CT 1980–2002 178 604 43 (0–350+), brain; 12 (0–50+) mGy, RBM Absorbed dose (57) (58)
12 PIRATES (low-dose) 1926–2000 107 594 30 (0–200) mGy, thyroid Absorbed dose (59) (60–62)
Occupational
13 Korean NW 1984–2004 79 679 6 (0–50+) mSv Effective dose (63) NA
14 Russian CL 1986–1987 357 51 (0–500+) mGy, RBM Absorbed dose (64) (65)
15 UKNRRW 1946–2001 174 541 25 (0–600+) mSv Equivalent dose (66) (25, 67)
16 Korean NPW 1978–2005 16 236 20 (0–480) mSv Effective dose (68) NA
17 Rocketdyne NW 1948–1999 5 801 14 (0–1000) mSv# Equivalent dose (69) (70)
18 Japanese NW 1957–2002 200 583 12 (0–<450) mSv** Effective dose (71) (72, 73)
19 Canadian NW 1956–1994 45 316 22 (0–679) mSv Equivalent dose (74) (75–77)
20 Ukrainian CL 1986–1987 1 000 82 (0–2600) mGy, RBM* Absorbed dose (78) (65, 79)
21 German NPW 1966–2008 8 972 30 (0–100+) mSv Effective dose (80) NA
22 US NW 1944–2005 119 195 20 (0–700) mSv H  p(10) (81) NA
23 INWORKS 1944–2005 308 297 21 (0–1332) mGy, colon; 16 (0–1218) mGy, RBM Absorbed dose (82, 83) (17, 84)
24 US atomic veterans 1945–1963 114 270 9 (0–580) mGy, RBM†† Absorbed dose (85) (86–88)
25 USRT 1916–1997 66 915, breast; 110 297, brain; 65 719, skin 37 (0–100+) mGy, breast; 12 (0–290) mGy, brain; 56 (0–1735) mGy, skin Absorbed dose (89–91) (92–94)
26 French NW 1950–2004 59 004 26 (0–669) mSv H  p(10) (95) (96, 97)
*

Values shown are for control population. BEIR = biological effects of ionizing radiation; CL = Chernobyl liquidators; CT = computed tomography; GB = Great Britain; Hp(10) = personal dose equivalent; INWORKS = International Nuclear Workers Study; NA = not applicable; NPW = nuclear power workers; NuTRIS = Nuclear Test Review Program Information System; NW = nuclear workers; PIRATES = Pooled International Radiation and Thyroid Cancer Epidemiology Studies; RBM = red bone marrow; TMI = Three Mile Island; UKNRRW = UK National Registry for Radiation Workers; USRT = US Radiologic Technologists.

Values shown are described as “likely” skin dose values. Range is from Gur et al. (98).

Person-year weighted average is shown.

§

From Davis et al. (44).

Median dose is shown.

Estimated from dose distribution.

#

External dose only.

**

Upper bound from Iwasaki et al. (73).

††

Adjusted NuTRIS dose from Beck et al. (99).